Animal cells and systems

The Korean Society for Integrative Biology (한국통합생물학회)
권호 표지

The Pst 1 Polymorphism of the Human Apolipoprotein AI Gene in Korean Elite Athletes

  • Published : 2003.03.01
Download PDF
⟨ Previous Next ⟩

Abstract

Serum lipid and lipoprotein levels are influenced by genetic factors, and exorcise increases the concentrations of cardio-protective parameters such as high-density lipoprotein cholesterol (HDL-cholesterol) and apolipoproteinAI (apoAI) in human serum. In the present study, we tested the effect of adaptation to endurance exercise on the association of a genetic polymorphism (Pst 1 RFLP) in the apoAI gene with these biochemical parameters. The genotype and allele frequencies for the Pst 1 RFLP were not significantly different between the elite athletes and sedentary controls (P>0.05). There were also no significant associations between the Pst 1 RFLP of the apoAI gene and the biochemical parameters in elite athletic group. Thus, our results suggest that the Pst 1 RFLP of the apoAI gene was not significantly associated with the serum apoAI and HDL-cholesterol concentrations as well as athletic performance in Koreans.

Keywords

References

  1. Bae JS, Kang BY, Kim KT, Shin JH, and Lee CC (2001) Genetic variation in six candidate genes for insulin resistance in Korean essential hypertensives. Korean J Biol Sci 5: 341-346 https://doi.org/10.1080/12265071.2001.9647625
  2. Boer JM, Kuivenhoven JA, Feskens EJ, Schouten EG, Havekes LM, Seidell JC, Kastelein JJ, and Kromhout D (1999) Physical activity modulates the effect of a lipoprotein lipase mutation (D9N) on plasma lipids and lipoproteins. Clin Genet 56: 158-163 https://doi.org/10.1034/j.1399-0004.1999.560212.x
  3. Botstein D, White RL, Skolnick M, and Davis RW (1980) Construction of a genetic linkage map in man using restriction fragment length polymorphisms. Am J Hum Genet 32: 314-331
  4. Friedwald WT, Levy Rl, and Friedrickson DS (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma without the use of the preparative ultracentrifuge. Clin Chem 18: 499-502
  5. Gayagay G, Yu B, Hambly B, Boston T, Hahn A, Celermajer DS, and Trent RJ (1998) Elite endurance athletes and the ACE I allele - the role of genes in athletic performance. Hum Genet 103: 48-50 https://doi.org/10.1007/s004390050781
  6. Groenendijk M, Cantor RM, de Bruin TW, and Dallinga-Thie GM (2001) The apoAI-CIII AIV gene cluster. Atherosclerosis 157: 1-11 https://doi.org/10.1016/S0021-9150(01)00539-1
  7. Hamsten A, Iselius L, Dahlen G, and Fraire U (1986) Genetic and cultural inheritance of serum lipids, low and high density lipoprotein cholesterol and serum apolipoproteins Al, All and B. Atherosclerosis 60: 199-208 https://doi.org/10.1016/0021-9150(86)90166-8
  8. Hill SA and McQueen MJ (1997) Reverse cholesterol transport: a review of the process and its clinical implications. Clin Biochem 30: 517-525 https://doi.org/10.1016/S0009-9120(97)00098-2
  9. Kang BY, Kang CY, Kim KT, Bae JS, Oh SD, Kim JH, and Lee KO (2002) Association study between the genetic variations of the apoAI-CIII-AIV gene cluster and hypertension among Koreans. J Toxicol Pub Health 18: 341-347
  10. Kang BY, Kim KT, Eo HS, Lee KH, Hong SS, Shin JH, and Lee CC (2000) Association between genetic variation of the insulin receptor gene and essential hypertension in the Korean population. Korean J Biol Sci 4: 87-90 https://doi.org/10.1080/12265071.2000.9647528
  11. Karathanasis SK (1986) Apolipoprotein multigene family tandem organization of apolipoprotein AIV, Al and Clll genes. Proc Natl Acad Sci USA 82: 6374-6378 https://doi.org/10.1073/pnas.82.19.6374
  12. Kessling AM, Horsthemke B, and Humphries SE (1985) A study of DNA polymorphisms around the human apolipop'otein Al gene in hyperlipidaemic and normal individuals. Clin Genet 28: 296-306 https://doi.org/10.1111/j.1399-0004.1985.tb00403.x
  13. Kessling AM, Rajput-Wiliams J, Bainton D, Scott J, IViller NE, Baker I, and Humphries SE (1988) DNA polymorphisms of the apolipoprotein All and AI-CIII-AIV genes: a study in men selected for differences in high density lipoprotein cholesterol concentration. Am J Hum Genet 42: 458-467
  14. Maciejko JJ, Holmes DR, Kottke BA, Zinsmeister AR, Dinh DM, and Mao SJT (1983) Apolipoprotein Al as a marker for angiographically assessed coronary artery disease. N Engl J Med 309: 385-389 https://doi.org/10.1056/NEJM198308183090701
  15. Miller NF, Forde OH, Fhelle SS, and Mjos OD (1977) The Tromso heart study: high density lipoprotein and coronary heart disease: a prospective case-control study. Lancet 1: 965-967
  16. Moll PP, Michel VV, Weidman WH, and Kottkell BA (1989) Genetic determination of plasma apolipoprotein Al in a population-based sample. Am J Hum Genet 44: 124-139
  17. Ordovas JM, Schaefer EJ, Salem D, Ward RH, Glueek CJ, Vergani C, Wilson PWF, and Karathanasis (1986) Apolipoprotein Al gene polymorphism associated with premature coronary artery disease and familial hypoalphalipoproteinaemia. N Engl J Med 413: 617-627
  18. Paulweber B, Friedl W, Krempler F, Humphries SE, and Sandhofer F (1988) Genetic variation in the apolipoprotein AI-CIII-AIV gene cluster and coronary heart disease. Atherosclerosis 73: 125-133 https://doi.org/10.1016/0021-9150(88)90033-0
  19. St-Amand J, Prud'homme D, Moorjani S, Nadeau A, Tremblay A, Bouchard C, Lupien PJ, and Despres JP (1999) Apolipoprotein E polymorphism and the relationships of physical fitness to plasma lipoprotein-lipid levels in men and women. Med Sci Sports Exerc 31: 692-697 https://doi.org/10.1097/00005768-199905000-00011
  20. Stromme JB, Inger F, and Meen HD (1977) Assessment of maximal aerobic power of specifically trained athletes. J Appl Physiol 42: 833-837 https://doi.org/10.1152/jappl.1977.42.6.833
  21. Taimela S, Lehtimaki T, Porkka KV, Rasanen L, and Viikari JS (1996) The effect of physical activity on serum total and low density lipoprotein cholesterol concentrations varies with apolipoprotein E phenotype in male children and younc adults: the Cardiovascular Risk in Young Finns Study. Metabolism 45: 797-803 https://doi.org/10.1016/S0026-0495(96)90149-3
  22. Williams PT, Wood PD, Haskel WL, and Vranizan K (1982) The effects of running mileage and duration on plasma lipoprotein levels. JAMA 247: 2674-2679 https://doi.org/10.1001/jama.247.19.2674
  23. Wood PD, Haskel WL, Blair SN, Williams PT, Krauss RM, Lindgren FT, Albers JJ, Ho PH, and Farquhar JW (1983) Increased exercise level and plasma lipoprotein concentrations: a one-year, randomized, controlled study in sedentary, middle- aged men. Metabolism 32: 31-39 https://doi.org/10.1016/0026-0495(83)90152-X
  24. Xu C-R, Boerwinkle E, Tikkanen MJ, Huttunen JK, Humphries SE, and Talmud PJ (1990) Genetic variation at the apolipoprotein gene loci contribute to response of plasma lipids to dietary charge. Genet Epidemiol 7: 261-276 https://doi.org/10.1002/gepi.1370070405
  25. Ziman MR and Jeenah MS (1995) The relationship between the Pst I restriction fragment length polymorphism at the apo-Al locus and plasma apo-AI concentrations in marathon runners. S Afr Med J 85: 1013-1016